Published in Br J Cancer on March 29, 2011
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol (2012) 1.59
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma. J Thorac Dis (2013) 1.27
Management of malignant pleural effusion. Lung (2013) 1.07
Diagnostic values of soluble mesothelin-related peptides for malignant pleural mesothelioma: updated meta-analysis. BMJ Open (2014) 0.90
Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma. Mol Cell Proteomics (2013) 0.89
A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancer. PLoS One (2014) 0.89
Combined serum mesothelin and carcinoembryonic antigen measurement in the diagnosis of malignant mesothelioma. Mol Clin Oncol (2013) 0.86
Pathological and molecular biological approaches to early mesothelioma. Int J Clin Oncol (2012) 0.84
MicroRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets. J Thorac Dis (2015) 0.82
Differential diagnosis of pleural mesothelioma using Logic Learning Machine. BMC Bioinformatics (2015) 0.82
Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies. Biomed Res Int (2014) 0.80
A potential therapeutic strategy for malignant mesothelioma with gene medicine. Biomed Res Int (2013) 0.79
Identification of novel autoantibodies for detection of malignant mesothelioma. PLoS One (2013) 0.77
Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo. Sci Rep (2016) 0.77
Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy. Int J Clin Oncol (2012) 0.76
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives. Respir Res (2017) 0.75
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
Empirical evidence of design-related bias in studies of diagnostic tests. JAMA (1999) 12.96
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol (2005) 10.56
Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med (1998) 9.15
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin Chem (2003) 7.92
Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med (2004) 6.87
The efficacy of diagnostic imaging. Med Decis Making (1991) 6.86
Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics (1983) 4.51
Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med (2005) 4.11
Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem (2005) 1.98
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2009) 1.85
Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma. Am J Respir Crit Care Med (2006) 1.46
Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax (2007) 1.32
Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond. Br J Cancer (2009) 1.31
The role of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma. Chest (1997) 1.31
Proposals for a phased evaluation of medical tests. Med Decis Making (2009) 1.25
Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology (2008) 1.17
Comparison of osteopontin, megakaryocyte potentiating factor, and mesothelin proteins as markers in the serum of patients with malignant mesothelioma. J Thorac Oncol (2008) 1.15
Criteria for scientific evaluation of novel markers: a perspective. Clin Chem (2010) 1.11
Advantages of the nested case-control design in diagnostic research. BMC Med Res Methodol (2008) 1.11
Toward complete and accurate reporting of studies of diagnostic accuracy. The STARD initiative. Am J Clin Pathol (2003) 1.10
Characteristics of good diagnostic studies. Semin Reprod Med (2003) 1.02
Biomarkers for mesothelioma. Curr Opin Pulm Med (2007) 1.02
Biomarkers for malignant pleural mesothelioma: current status. Mol Diagn Ther (2008) 1.01
Diagnostic value of soluble mesothelin-related peptides for malignant mesothelioma: a meta-analysis. Respir Med (2009) 1.00
Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med (2009) 1.00
A molecular diagnostic test for distinguishing lung adenocarcinoma from malignant mesothelioma using cells collected from pleural effusions. Clin Cancer Res (2006) 0.96
The Portsmouth thoracoscopy experience, an evaluation of service by retrospective case note analysis. Respir Med (2006) 0.88
Accuracy and reproducibility of pleural effusion cytology. Leg Med (Tokyo) (2007) 0.86
Cytologic malignancy versus benignancy: how useful are the "newer" markers in body fluid cytology? Arch Pathol Lab Med (2008) 0.86
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
External validation is necessary in prediction research: a clinical example. J Clin Epidemiol (2003) 3.49
Excluding venous thromboembolism using point of care D-dimer tests in outpatients: a diagnostic meta-analysis. BMJ (2009) 2.86
Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol (2008) 2.81
Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. BMJ (2014) 2.80
Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis. BJOG (2014) 2.20
Preoperative prediction of severe postoperative pain. Pain (2003) 2.11
Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol (2007) 2.01
Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain (2008) 1.67
A clinical prediction model to assess the risk of operative delivery. BJOG (2012) 1.65
Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth (2005) 1.62
Inter- and intra-observer agreement of intrapartum ST analysis of the fetal electrocardiogram in women monitored by STAN. BJOG (2009) 1.57
FOLLOWPACE study: a prospective study on the cost-effectiveness of routine follow-up visits in patients with a pacemaker. Europace (2006) 1.52
Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart (2011) 1.52
Discontinuation of yellow jacket venom immunotherapy: follow-up of 75 patients by means of deliberate sting challenge. J Allergy Clin Immunol (1997) 1.49
Validation of a clinical prediction rule to reduce preoperative type and screen procedures. Br J Anaesth (2002) 1.46
Incidence and predictors of in-hospital events after first implantation of pacemakers. Europace (2007) 1.46
Jugular bulb desaturation during coronary artery surgery: a comparison of off-pump and on-pump procedures. Br J Anaesth (2005) 1.41
Pre-operative detection of valvular heart disease by anaesthetists. Anaesthesia (2006) 1.41
Pulse contour cardiac output derived from non-invasive arterial pressure in cardiovascular disease. Anaesthesia (2010) 1.40
[Treatment of patients with herpes zoster by epidural injection of steroids and local anaesthetics: less pain after 1 month, but no effect on long-term postherpetic neuralgia--a randomised trial]. Ned Tijdschr Geneeskd (2006) 1.39
Identifying patients for blood conservation strategies. Br J Surg (2002) 1.38
Polytomous logistic regression analysis could be applied more often in diagnostic research. J Clin Epidemiol (2007) 1.26
Excluding deep vein thrombosis safely in primary care. J Fam Pract (2006) 1.17
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia (2010) 1.11
Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule. Diabetologia (2009) 1.11
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma. Br J Cancer (2002) 1.10
Validating and updating a prediction rule for serious bacterial infection in patients with fever without source. Acta Paediatr (2007) 1.09
Multiple imputation to correct for partial verification bias revisited. Stat Med (2008) 1.05
Cost-effectiveness of ruling out deep venous thrombosis in primary care versus care as usual. J Thromb Haemost (2009) 1.02
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD Statement. Br J Surg (2015) 0.96
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study. Br J Cancer (2006) 0.95
Prognosis and prognostic factors of patients with mesothelioma: a population-based study. Br J Cancer (2012) 0.95
E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training. Br J Dermatol (2012) 0.94
A new diagnostic rule for deep vein thrombosis: safety and efficiency in clinically relevant subgroups. Fam Pract (2008) 0.94
Diagnostic and prognostic prediction models. J Thromb Haemost (2013) 0.93
A model to predict patient temperature during cardiac surgery. Phys Med Biol (2007) 0.92
Resolving the blind spot of transoesophageal echocardiography: a new diagnostic device for visualizing the ascending aorta in cardiac surgery. Br J Anaesth (2007) 0.91
Common carotid intima-media thickness does not add to Framingham risk score in individuals with diabetes mellitus: the USE-IMT initiative. Diabetologia (2013) 0.91
Assessing the applicability of scoring systems for predicting postoperative nausea and vomiting. Anaesthesia (2005) 0.89
Sarcopenic obesity is associated with adverse clinical outcome after cardiac surgery. Nutr Metab Cardiovasc Dis (2012) 0.89
Early prediction of neurological sequelae or death after bacterial meningitis. Acta Paediatr (2002) 0.87
Meta-analysis of the diagnostic accuracy of transesophageal echocardiography for assessment of atherosclerosis in the ascending aorta in patients undergoing cardiac surgery. Acta Anaesthesiol Scand (2008) 0.87
Association between early and three month cognitive outcome after off-pump and on-pump coronary bypass surgery. Heart (2004) 0.86
Systematic review: diagnostic accuracy of clinical decision rules for venous thromboembolism in elderly. Ageing Res Rev (2010) 0.86
Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. Cancer Chemother Pharmacol (2011) 0.86
Non-small cell lung carcinoma of the superior sulcus: favourable outcomes of combined modality treatment in carefully selected patients. Lung Cancer (2007) 0.85
Vascular rings and pulmonary arterial sling: from respiratory collapse to surgical cure, with emphasis on judicious imaging in the hi-tech era. Cardiol Young (2002) 0.84
Central diabetes insipidus and Cushing's syndrome due to ectopic ACTH production by disseminated small cell lung cancer: a case report. Neth J Med (1998) 0.84
Diagnostic accuracy of modified transoesophageal echocardiography for pre-incision assessment of aortic atherosclerosis in cardiac surgery patients. Br J Anaesth (2010) 0.83
The accuracy of trained nurses in pre-operative health assessment: results of the OPEN study. Anaesthesia (2004) 0.83
Dementia: predictors of diagnostic accuracy and the contribution of diagnostic recommendations. J Fam Pract (2002) 0.83
Occupational asbestos exposure: how to deal with suspected mesothelioma cases--the Dutch approach. Ann Oncol (2006) 0.83
Tubulin, BRCA1, ERCC1, Abraxas, RAP80 mRNA expression, p53/p21 immunohistochemistry and clinical outcome in patients with advanced non small-cell lung cancer receiving first-line platinum-gemcitabine chemotherapy. Lung Cancer (2011) 0.82
Role of history and physical examination in preoperative evaluation. Eur J Anaesthesiol (2003) 0.82
Influence of dilated cardiomyopathy and a left ventricular assist device on vortex dynamics in the left ventricle. Comput Methods Biomech Biomed Engin (2008) 0.82
A model system for optimising the selection of membrane antigen-specific human antibodies on intact cells using phage antibody display technology. J Immunol Methods (2002) 0.80
Diagnostic management of chronic obstructive pulmonary disease. Neth J Med (2012) 0.80
Effect of rewarming speed during hypothermic cardiopulmonary bypass on cerebral pressure-flow relation. Acta Anaesthesiol Scand (2002) 0.80
Prediction of low haemoglobin levels in whole blood donors. Vox Sang (2010) 0.80
Patients' characteristics associated with readmission to a surgical intensive care unit. Am J Crit Care (2012) 0.80
Modeling length of stay as an optimized two-class prediction problem. Methods Inf Med (2007) 0.79
The effect of national guidelines on the implementation of outpatient preoperative evaluation clinics in Dutch hospitals. Eur J Anaesthesiol (2006) 0.79
Internal validation of risk models in clustered data: a comparison of bootstrap schemes. Am J Epidemiol (2013) 0.78
Mapping use of radiotherapy for patients with non-small cell lung cancer in the Netherlands between 1997 and 2008. Clin Oncol (R Coll Radiol) (2011) 0.78
Common alternative diagnoses in general practice when deep venous thrombosis is excluded. Neth J Med (2012) 0.78
The effect of zero-balanced ultrafiltration during cardiopulmonary bypass on S100b release and cognitive function. Perfusion (2003) 0.78
Predictive performance of a physiological model for enflurane closed-circuit anaesthesia: effects of continuous cardiac output measurements and age-related solubility data. Br J Anaesth (2002) 0.78
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BJOG (2015) 0.77
Topical vascular endothelial growth factor in rabbit tracheal surgery: comparative effect on healing using various reconstruction materials and intraluminal stents. Eur J Cardiothorac Surg (2003) 0.77
Understanding post-operative temperature drop in cardiac surgery: a mathematical model. Math Med Biol (2008) 0.77
Endovascular treatment of thoracic aortic pathology: feasibility and mid-term results. Eur J Vasc Endovasc Surg (2003) 0.77
Cost-effectiveness of radioguided occult lesion localization (ROLL) versus wire-guided localization (WGL) in breast conserving surgery for nonpalpable breast cancer: results from a randomized controlled multicenter trial. Ann Surg Oncol (2013) 0.76
Risk control of surgical site infection after cardiothoracic surgery. J Hosp Infect (2006) 0.76
The FOLLOWPACE study: a prospective study on the (cost-)effectiveness of routine follow-up visits in patients with a pacemaker. Neth Heart J (2004) 0.75
[Guideline 'Radiotherapy in non-small-cell lung carcinoma']. Ned Tijdschr Geneeskd (1998) 0.75
D-dimer testing in elderly patients in primary care for exclusion of venous thromboembolism. J Thromb Haemost (2008) 0.75
Measurement of platelet-activating factor in biological specimens. J Lipid Mediat (1992) 0.75
The intracarotid amobarbital or Wada test: unilateral or bilateral? Acta Neurol Scand (2008) 0.75
[Support of damaged heart with the Impella pump]. Ned Tijdschr Geneeskd (2017) 0.75
[Systematic detection of physical child abuse at emergency rooms]. Ned Tijdschr Geneeskd (2016) 0.75
Design issues for studies into prevention of chronic pain: lessons from post-herpetic neuralgia. Anaesthesia (2004) 0.75
Fetal blood sampling in addition to intrapartum ST-analysis of the fetal electrocardiogram: evaluation of the recommendations in the Dutch STAN® trial. BJOG (2011) 0.75
Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A. Haemophilia (2014) 0.75
Classifying the probability of urinary incontinence in psychogeriatric nursing home patients. Arch Gerontol Geriatr (2002) 0.75
Talc instillation consensus AIDS differentiating successful from unsuccessful pleurodesis: a survey on the interpretation of pleural approximation after chest tube placement. Respiration (2012) 0.75
Observing stage-shifts in head and neck squamous cell carcinoma from initial clinical outpatient staging to definite clinical tumour board staging using radiological and endoscopical investigations: will less do? Clin Otolaryngol (2011) 0.75
Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue. Bioanalysis (2012) 0.75
[Development in the treatment of malignant mesothelioma]. Ned Tijdschr Geneeskd (2005) 0.75
Breast-feeding and health consequences in early childhood: is there an impact of time-dependent confounding? Ann Nutr Metab (2014) 0.75
[Problematic cases of mesothelioma reported to the Dutch Institute for Asbestos Victims: evaluation by the Mesothelioma Working Group of the Netherlands Association of Pulmonologists and Specialists in Tuberculosis]. Ned Tijdschr Geneeskd (2005) 0.75
Visceral and renal tissue oxygenation during supraceliac aortic crossclamping and left heart bypass with selective organ perfusion. Eur J Vasc Endovasc Surg (2004) 0.75
Aortic root pathology in Marfan syndrome increases the risk of migraine with aura. Cephalalgia (2012) 0.75
[Financial compensation for asbestosis patients]. Ned Tijdschr Geneeskd (2016) 0.75